NEW YORK, NY / ACCESS Newswire / September 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cybin Inc. ("Cybin" or "the Company") (NYSE:CYBN). Investors who purchased Cybin securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/CYBN. Investigation Details […]
NEW YORK CITY, NY / ACCESS Newswire / September 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT). Investors who purchased Applied Therapeutics securities prior to January 3, 2024, and continue to hold to the present, are encouraged
Mopec, a leader in pathology and anatomy innovation, is proud to announce the next chapter in its collaboration with Lumea, a pioneer in digital pathology technology. Building on the companies' existing partnership, Mopec will integrate Lumea's patented tissue-handling technology directly into the Mopec Maestro® Encore Grossing Station, further advancing diagnostic accuracy and workflow efficiency for
The law firm of Kessler Topaz Meltzer & Check, LLP(www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Dow Inc. (“Dow”) (NYSE: DOW) on behalf of those who purchased or otherwise acquired Dow securities between January 30, 2025, and July 23, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is
NEW YORK CITY, NY / ACCESS Newswire / September 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ibotta, Inc. ("Ibotta" or "the Company") (NYSE:IBTA). Investors who purchased Ibotta securities prior to April 18, 2024, and continue to hold to the present, are encouraged to obtain additional
NEW YORK CITY, NY / ACCESS Newswire / September 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Avis Budget Group, Inc. ("Avis Budget" or "the Company") (NASDAQ:CAR). Investors who purchased Avis Budget securities prior to February 13, 2024, and continue to hold to the present, are
NEW YORK CITY, NY / ACCESS Newswire / September 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of RxSight, Inc. ("RxSight" or "the Company") (NASDAQ:RXST). Investors who purchased RxSight securities prior to November 7, 2024, and continue to hold to the present, are encouraged to obtain additional
NEW YORK CITY, NY / ACCESS Newswire / September 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ModivCare, Inc. ("ModivCare" or "the Company") (NASDAQ:MODV). Investors who purchased ModivCare securities prior to November 3, 2022, and continue to hold to the present, are encouraged to obtain additional
NEW YORK CITY, NY / ACCESS Newswire / September 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Paragon 28, Inc. ("Paragon 28" or "the Company") (NYSE:FNA). Investors who purchased Paragon 28 securities prior to May 5, 2023, and continue to hold to the present, are encouraged
NEW YORK, NY / ACCESS Newswire / September 28, 2025 / If you suffered a loss on your Unicycive Therapeutics, Inc. (NASDAQ:UNCY) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/unicycive-therapeutics-inc-lawsuit-submission-form?prid=169820&wire=1&utm_campaign=10 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or